Free tool
Diagnostics stocks
We cover 52 companies grouped under the Diagnostics theme. The median market value in the group is $44.08M. Across the group, the median move over the past trading day is 0.00%. 38% of the 50 with a 200-day average trade above it. Price change over the past year runs from −72.0% to +9.1% across the middle 80 percent of the group, with a median of −16.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
52 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| QIA.DE | Qiagen N.V. | 36.41 EUR | −0.78% | −4.56% | −11.42% |
| ALIF-B.ST | AddLife AB (publ) | 162.40 SEK | +0.74% | +8.24% | −7.56% |
| DIA.WA | Diagnostyka S.A. | 166.50 PLN | +0.54% | −3.70% | −17.53% |
| CEVI.ST | CellaVision AB (publ) | 167.40 SEK | +15.93% | +13.18% | −3.32% |
| VOX.WA | Voxel S.A. | 130.40 PLN | +2.68% | +7.24% | −20.15% |
| NIOX.L | NIOX Group Plc | 68.00 GBP | +11.48% | +0.03% | −6.05% |
| 0K3W.L | Myriad Genetics, Inc. | $3.15 | +2.95% | −49.12% | −46.71% |
| N3B.F | Anbio Biotechnology | 5.50 EUR | −36.78% | −67.46% | −86.59% |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $4.42 | +2.67% | −36.40% | +80.26% |
| SBS.DE | Stratec SE | 22.35 EUR | +7.97% | +1.13% | −16.29% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −0.73% | −21.91% | +20.85% |
| 0RAR.L | Stratec SE | 23.05 EUR | +2.67% | +4.06% | −13.37% |
| ALERS.PA | Eurobio Scientific Société anonyme | 20.50 EUR | −3.76% | −15.11% | −18.97% |
| S2B.WA | Syn2bio S.A. | 64.90 PLN | −5.94% | +81.79% | +81.79% |
| 0ELV.L | Guerbet SA | 7.88 EUR | −0.63% | −47.47% | −62.12% |
| EKF.L | EKF Diagnostics Holdings plc | 25.40 GBP | −3.42% | −4.33% | −13.90% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| SCP.WA | Scope Fluidics S.A. | 139.80 PLN | +19.28% | 0.00% | −9.34% |
| S84.F | Scope Fluidics S.A. | 27.75 EUR | +19.87% | −25.90% | −9.76% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.60 SEK | −12.61% | −47.54% | −60.27% |
| BIOPOR.CO | BioPorto A/S | 1.20 DKK | −0.41% | +15.16% | −6.25% |
| 7V0.DE | Novogenia AG | 6.10 EUR | −0.81% | −20.26% | −29.07% |
| ALKLH.PA | KLEA HOLDING | 0.16 EUR | −1.90% | −30.34% | −29.55% |
| BIOBV.HE | Biohit Oyj | 2.56 EUR | −6.57% | −28.89% | −8.24% |
| 0DRP.L | Biohit Oyj | 2.60 EUR | −5.63% | −6.31% | −6.31% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.36 EUR | −1.67% | −38.54% | −47.32% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +14.60% | +22.38% | +8.44% |
| NCYT.L | Novacyt S.A. | 44.00 GBP | +20.55% | +22.39% | +9.18% |
| ABDX.L | Abingdon Health Plc | 11.00 GBP | +11.68% | +71.87% | +100.00% |
| ACARIX.ST | Acarix AB (publ) | 0.23 SEK | −7.36% | −13.70% | −15.27% |
| GDR.L | genedrive plc | 1.38 GBP | +38.00% | +57.71% | +78.06% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −11.48% | +20.13% | −6.09% |
| ALIKO.PA | Ikonisys S.A. | 1.46 EUR | −2.67% | −9.60% | −3.95% |
| RENX.L | Renalytix Plc | 4.25 GBP | +60.38% | −27.97% | −27.35% |
| ALBIO.PA | Biosynex SA | 0.92 EUR | −0.43% | +58.48% | −22.70% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −80.77% |
| URT.WA | Urteste S.A. | 43.50 PLN | +0.93% | +2.35% | −14.03% |
| GMT.WA | Genomtec S.A. | 3.75 PLN | −6.60% | −0.53% | −38.02% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.44 SEK | −12.60% | +1.39% | −33.59% |
| BACTIQ.CO | BactiQuant A/S | 2.40 DKK | +2.56% | −35.31% | −6.98% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.21 SEK | −8.29% | −39.20% | −46.85% |
| CRM.WA | PZ Cormay S.A. | 0.52 PLN | +5.48% | +26.83% | +2.77% |
| BMX.WA | BioMaxima S.A. | 10.14 PLN | +1.60% | −17.89% | −22.30% |
| GENI.L | GENinCode Plc | 0.88 GBP | +6.06% | −63.54% | −37.50% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.62 SEK | +18.73% | −81.05% | −87.29% |
| OBD.L | Oxford BioDynamics Plc | 0.13 GBP | 0.00% | −48.00% | −72.63% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | +0.91% | −64.98% | −65.85% |
| 2CUREX.ST | 2cureX AB (publ) | 0.51 SEK | −71.95% | −5.02% | −79.23% |
| 0G8X.L | Immunovia AB (publ) | 0.15 SEK | −11.14% | −33.92% | −83.18% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.